Skip to content

Press Releases

Date Title
Sep 23, 2020 Illumina to Webcast Upcoming Investor Conference Presentation
Sep 21, 2020 Illumina to Acquire GRAIL to Launch New Era of Cancer Detection
Sep 14, 2020 Genomic Leaders Collaborate to Create Australia’s First National COVID-19 Tracking System
Aug 25, 2020 Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
Aug 7, 2020 Illumina to Webcast Upcoming Investor Conference Presentation
Aug 6, 2020 Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome
Aug 6, 2020 Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020
Jul 16, 2020 Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Jul 8, 2020 Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
Jun 23, 2020 Illumina Accelerator Welcomes First Global Cohort of Genomics Startups
Jun 17, 2020 Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale
Jun 16, 2020 Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies
Jun 9, 2020 Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
May 18, 2020 Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
May 4, 2020 Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development
Apr 30, 2020 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
Apr 28, 2020 Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
Apr 16, 2020 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
Apr 14, 2020 Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020
Feb 27, 2020 Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
Feb 12, 2020 Illumina to Webcast Upcoming Investor Conference Presentations
Feb 6, 2020 Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
Jan 29, 2020 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
Jan 13, 2020 Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020
Jan 13, 2020 Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics
Jan 13, 2020 Illumina and Roche Partner to Broaden Patient Access to Genomic Testing
Jan 10, 2020 Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
Jan 2, 2020 Illumina and Pacific Biosciences Announce Termination of Merger Agreement